UBS Group’s Neptune Wellness Solutions Inc. Ordinary Shares NEPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,694
| Closed | -$1.43K | – | 10339 |
|
|
2023
Q4 | $1.43K | Sell |
2,694
-4,704
| -64% | -$3.47K | ﹤0.01% | 8305 |
|
|
2023
Q3 | $9.77K | Buy |
7,398
+7,396
| +369,800% | +$40.3K | ﹤0.01% | 7123 |
|
|
2023
Q2 | $10 | Sell |
2
-102
| -98% | -$1.46K | ﹤0.01% | 8738 |
|
|
2023
Q1 | $2.25K | Buy |
104
+103
| +10,300% | +$2.47K | ﹤0.01% | 8543 |
|
|
2022
Q4 | $18 | Sell |
1
-98
| -99% | -$3.69K | ﹤0.01% | 10556 |
|
|
2022
Q3 | $6K | Sell |
99
-140
| -59% | -$9.55K | ﹤0.01% | 9110 |
|
|
2022
Q2 | $13K | Buy |
239
+238
| +23,800% | +$48.3K | ﹤0.01% | 7578 |
|
|
2022
Q1 | $0 | Sell |
1
-57
| -98% | -$25.9K | ﹤0.01% | 11154 |
|
|
2021
Q4 | $33K | Buy |
58
+30
| +107% | +$20.6K | ﹤0.01% | 7311 |
|
|
2021
Q3 | $23K | Buy |
28
+27
| +2,700% | +$28.5K | ﹤0.01% | 7032 |
|
|
2021
Q2 | $2K | Sell |
1
-1
| -50% | -$1.81K | ﹤0.01% | 9014 |
|
|
2021
Q1 | $4K | Sell |
2
-7
| -78% | -$17.7K | ﹤0.01% | 8447 |
|
|
2020
Q4 | $19K | Sell |
9
-5
| -36% | -$12.8K | ﹤0.01% | 6996 |
|
|
2020
Q3 | $40K | Buy |
14
+4
| +40% | +$15.2K | ﹤0.01% | 5807 |
|
|
2020
Q2 | $40K | Sell |
10
-2
| -17% | -$6.71K | ﹤0.01% | 6074 |
|
|
2020
Q1 | $20K | Sell |
12
-12
| -50% | -$34.2K | ﹤0.01% | 6509 |
|
|
2019
Q4 | $91K | Sell |
24
-1
| -4% | -$4.34K | ﹤0.01% | 6057 |
|
|
2019
Q3 | $125K | Buy |
25
+19
| +317% | +$124K | ﹤0.01% | 5621 |
|
|
2019
Q2 | $34K | Hold |
6
| – | – | ﹤0.01% | 6243 |
|
|
2019
Q1 | $25K | Sell |
6
-2
| -25% | -$9.54K | ﹤0.01% | 6116 |
|
|
2018
Q4 | $29K | Sell |
8
-25
| -76% | -$121K | ﹤0.01% | 6513 |
|
|
2018
Q3 | $181K | Buy |
33
+31
| +1,550% | +$150K | ﹤0.01% | 5146 |
|
|
2018
Q2 | $9K | Sell |
2
-4
| -67% | -$16.1K | ﹤0.01% | 7210 |
|
|
2018
Q1 | $22K | Sell |
6
-21
| -78% | -$87.1K | ﹤0.01% | 6361 |
|
|
2017
Q4 | $90K | Buy |
27
+23
| +575% | +$41.7K | ﹤0.01% | 5437 |
|
|
2017
Q3 | $5K | Sell |
4
-16
| -80% | -$19.1K | ﹤0.01% | 7246 |
|
|
2017
Q2 | $24K | Buy |
20
+7
| +54% | +$9.73K | ﹤0.01% | 6174 |
|
|
2017
Q1 | $19K | Buy |
13
+4
| +44% | +$5.9K | ﹤0.01% | 6184 |
|
|
2016
Q4 | $13K | Buy |
9
+5
| +125% | +$7.63K | ﹤0.01% | 6775 |
|
|
2016
Q3 | $6K | Hold |
4
| – | – | ﹤0.01% | 7073 |
|
|
2016
Q2 | $6K | Hold |
4
| – | – | ﹤0.01% | 7060 |
|
|
2016
Q1 | $5K | Sell |
4
-3
| -43% | -$4.49K | ﹤0.01% | 7022 |
|
|
2015
Q4 | $10K | Sell |
7
-3
| -30% | -$4.78K | ﹤0.01% | 7296 |
|
|
2015
Q3 | $15K | Buy |
10
+6
| +150% | +$11.1K | ﹤0.01% | 6976 |
|
|
2015
Q2 | $7K | Hold |
4
| – | – | ﹤0.01% | 7720 |
|
|
2015
Q1 | $9K | Sell |
4
-3
| -43% | -$7.47K | ﹤0.01% | 7743 |
|
|
2014
Q4 | $18K | Buy |
+7
| New | +$17.5K | ﹤0.01% | 7811 |
|
Other funds holding NEPT
UBS Group's NEPT Position: Q1 2024 in Review
UBS Group sold out of Neptune Wellness Solutions Inc. Ordinary Shares (NEPT) in Q1 2024, closing a stake of 2,694 shares — an estimated $1.43K sold.
UBS Group first reported a position in NEPT in Q4 2014 and held it in 37 quarters. The position peaked at $181K in Q3 2018. 1 fund tracked by Wall St. Rank holds NEPT as of Q1 2024.
- UBS Group reported no remaining Neptune Wellness Solutions Inc. Ordinary Shares position as of Q1 2024 after selling out during the quarter.
- UBS Group sold 2,694 Neptune Wellness Solutions Inc. Ordinary Shares shares in Q1 2024, an estimated $1.43K.
- UBS Group first reported a position in Neptune Wellness Solutions Inc. Ordinary Shares in Q4 2014 and held it in 37 quarters.
- UBS Group's Neptune Wellness Solutions Inc. Ordinary Shares position peaked at $181K in Q3 2018.
- 1 fund tracked by Wall St. Rank held Neptune Wellness Solutions Inc. Ordinary Shares as of Q1 2024.
Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.